Clinical evaluation of rubella vaccine, Cendehill strain.
D000293:Adolescent; D000328:Adult; D000906:Antibodies / Q000032:analysis; D002648:Child; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007592:Joint Diseases / Q000209:etiology; D008875:Middle Aged; D010146:Pain / Q000209:etiology; D049590:Postpartum Period; D011247:Pregnancy; D012409:Rubella / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000009:adverse effects; D012412:Rubella virus / Q000302:isolation & purification; D013997:Time Factors; D014765:Viral Vaccines
D000906:Antibodies; D012411:Rubella Vaccine; D014765:Viral Vaccines